首页> 外国专利> METHOD OF USING NUTRITIONAL COMPOUNDS DIHYDROQUERCETIN (TAXIFOLIN) AND ARABINOGALACTAN IN COMBINATION WITH DIHYDROQUERCETIN (TAXIFOLIN) TO REDUCE AND CONTROL CARDIOMETABOLIC RISKFACTORS ASSOCIATED WITH METABOLIC SYNDROME AND HYPERCHOLESTEROLEMIA

METHOD OF USING NUTRITIONAL COMPOUNDS DIHYDROQUERCETIN (TAXIFOLIN) AND ARABINOGALACTAN IN COMBINATION WITH DIHYDROQUERCETIN (TAXIFOLIN) TO REDUCE AND CONTROL CARDIOMETABOLIC RISKFACTORS ASSOCIATED WITH METABOLIC SYNDROME AND HYPERCHOLESTEROLEMIA

机译:营养化合物二氢槲皮素(塔西弗林)和阿拉伯糖精与二氢槲皮素(塔西弗林)结合使用以减少和控制与代谢综合征和高胆固醇有关的心血管危险因素的方法

摘要

The method of using nutritional compounds including Dihydroquercetin (taxifolin), Arabinogalactan and Arabinogalactan combined with Dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors, associated with metabolic syndrome and hypercholesterolemia in a mammal, specifically a human, resulting in the enhancement of metabolism, reduced control levels of cholesterol and triglycerides, reduced oxidative damage in humans and other health benefits.
机译:使用包括二氢槲皮素(紫杉醇),阿拉伯半乳聚糖和阿拉伯半乳聚糖与二氢槲皮素(紫杉醇)的营养化合物来降低和控制与代谢综合征和高胆固醇血症相关的心血管代谢危险因素的方法,该代谢因子和哺乳动物的胆固醇升高,特别是人类,导致代谢增强,降低了胆固醇和甘油三酸酯的控制水平,降低了人体的氧化损伤以及其他健康益处。

著录项

  • 公开/公告号CA2868835A1

    专利类型

  • 公开/公告日2013-10-17

    原文格式PDF

  • 申请/专利权人 FLAVITPURE INC.;

    申请/专利号CA20122868835

  • 发明设计人 PHILIPPOV SERGEY;BOGORODOV IGOR;

    申请日2012-09-18

  • 分类号A23L1/29;A23L1/30;A23L2/52;A23P1/02;

  • 国家 CA

  • 入库时间 2022-08-21 16:37:35

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号